- Dr. Jim Cross talks about why he recommends Baker Tilly healthcare as a company that makes it more understandable and easier for the client to reach their goals.
- Baker Tilly Capital, LLC's Life sciences M&A newsletter provides an overview of the current industry's marketplace, highlighting key trends impacting performance and U.S. M&A activity.
- Baker Tilly’s international tax professionals discuss the role of IP migration for life sciences companies.
- Former CFO of Vascular Solutions (sold to Teleflex in 2016), describes his experience and the benefits of working with the Baker Tilly life sciences team.
- This webinar for manufacturers features an interactive panel discussion on what it takes to manage cybersecurity risk without full-time cybersecurity expertise on staff.